None listed
Conditions
Interventions
None listed
Sponsors
Seoul National University Bundang Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Among all adult (>=18years) patient with MSSA bacteremia at participating hospitals was ascertained during the study period 1) Patient who received cefazolin or nafcillin as definite antibiotics 2) Patient who agree the gathering clinical information about S. aureus bacteremia by inform consent. 3) Patient who fulfill the criteria of waiver of informed consent: Patient who died or transferred within 2 weeks after the onset of bacteremia was waived by institutional review board.
Exclusion criteria
Exclusion criteria: Patient who do not agree the participation in this study, except for patient who fulfill the criteria of waiver of informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment failure: [(1) switching antibiotics due to clinical failure; (2) premature discontinuation of antibiotics due to drug adverse effect, (3) recurrence of MSSA bacteremia, or (4) MSSA bacteremia associated mortality];3 months mortality | — |
Secondary
| Measure | Time frame |
|---|---|
| Persistent bacteremia;7day mortality;Analysis of clinical implication of cefazolin inoculum effect | — |
Countries
Korea, Republic of
Contacts
Public ContactShinwon Lee
Pusan National University Hospital
Outcome results
None listed